ClinicalTrials.gg
Not yet recruitingNCT07153523Updated Nov 6, 2026

Effect of High Intensity Interval Training on Strength, Endurance and Flexibility

An interventional study of High intensity interval training and Routine physical therapy in High Intensity Interval Training, sponsored by University of Health Sciences Lahore. Not yet recruiting at 2 sites in Pakistan. Open to participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by University of Health Sciences Lahore · Not applicable, Interventional, and Treatment

How we know

Updated Nov 6, 2026Now Not yet recruitingStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 24 Years
Sex
All
01

Study summary

Strength and endurance are essential components for physical fitness of any individual. High intensity interval training provides time efficient benefits for strength and endurance training. Physical Therapy professionals and students need physical fitness for effective clinical performance of patients. There is limited research regarding physical performance of physical therapists itself

Read the detailed description

Physical fitness is defined as capacity of doing physical activity using muscular efforts, resulting in energy expenditure. It is dependent upon body composition, muscle strength, endurance and flexibility of person. Pre assessment of strength, endurance and flexibility among physical therapy students will measure their physical fitness and findings from High intensity interval training (HIIT) will help further clinicians for designing fitness program to enhance physical abilities of future physical therapists. This study will address the gap by finding effects of HIIT that would help to improve fitness level of physical therapy students and influence exercise prescription.

Objective: To determine effects of high intensity interval training versus conservative treatment for strength, endurance and flexibility of undergraduate physical therapy students

02

Conditions studied

  • High Intensity Interval Training

Keywords

  • high intensity interval training
03

In context

Lead sponsor

University of Health Sciences Lahore is the lead sponsor of 83 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate physical therapy students aged 18-24 years.
  • Both genders male and female
  • DPT students from 1st to final year

Exclusion criteria

Exclusion Criteria:

  • Students with musculoskeletal pain and injuries.
  • Any neurological and cardiovascular restrictions.
  • Any trauma like fracture.
  • Surgical limitation of range of motion.
  • Any systemic disease.
  • Malignant or benign Tumor.
  • Students who are athletes or doing regular exercise
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Experimental arm

    High intensity interval training

    Other: High intensity interval training

  • Active comparator
    Control arm

    routine physical therapy

    Other: Routine physical therapy

Interventions

  • OtherHigh intensity interval training

    High intensity interval training provides time efficient benefits for strength and endurance training. It comprises of high burst training with rest periods. For experimental group HIIT training will be applied comprising of burpees, squats, arm walking and lunges. The exercise will be given 3 times/ week for 4 weeks. For standardization experimental group will receive 10 minutes of warm up and cool down period comprising of stretching exercises

  • OtherRoutine physical therapy

    For control group routine physical therapy will be applied for strength training using weights and running drills for endurance training. The exercise will be given 3 times/ week for 4 weeks. For standardization control group will receive 10 minutes of warm up and cool down period comprising of stretching exercises

06

What researchers measure

Primary outcomes

  1. Strength

    The grip strength will be measured using Hand Held Dynamometer (model). Lower limb strength will be measured through vertical jump test

    Time frame: From enrollment to the end of treatment at 4 weeks

  2. Muscle endurance

    The sit-up test will be used to assess muscular endurance

    Time frame: From enrollment to the end of treatment at 4 weeks

  3. Flexibility

    The flexibility will be assessed using sit and reach test

    Time frame: From enrollment to the end of treatment at 4 weeks

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Nov 2026; primary completion for Jan 2027, 1 month later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: start Mar 2026 → Nov 2026, primary completion Jun 2026 → Jan 2027 and completion Jun 2026 → Jan 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2025
First posted
Sep 4, 2025
StartEst.
Nov 30, 2026was Mar 2026
Primary completionEst.
Jan 15, 2027was Jun 2026
CompletionEst.
Jan 15, 2027was Jun 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Not yet recruiting
changed Nov 6, 2026
Start date
Mar 2, 2026→Nov 30, 2026
Nov 6, 2026
Primary completion
Jun 15, 2026→Jan 15, 2027
Nov 6, 2026
Study completion
Jun 15, 2026→Jan 15, 2027
Nov 6, 2026
Enrollment
66→72
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Recruiting→Not yet recruiting
    Start date Mar 2, 2026→Nov 30, 2026
    Primary completion Jun 15, 2026→Jan 15, 2027
    Study completion Jun 15, 2026→Jan 15, 2027
    Enrollment 66→72
    + 2 other changes: verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07153523
Lead sponsor
University of Health Sciences Lahore
Responsible party
Wajeeha Mahmood (Dr Wajeeha Mahmood(PT), University of Health Sciences Lahore) — Principal investigator
First posted
Sep 4, 2025
Start date
Nov 30, 2026 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Nov 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion